Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALXN | MRNA | BIIB | ||
| Company | Alexion Pharm Inc | Moderna Inc | Biogen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 181.04 | 106.18 | 201.22 | ||
| High | 182.67 | 108.19 | 210.83 | ||
| Low | 180.13 | 105.25 | 199.10 | ||
| Last | 182.50 | 107.97 | 208.90 | ||
| Change | +3.05 | +1.79 | +6.44 | ||
| % Change | +1.70% | +1.69% | +3.18% | ||
| Volume | 90,506,096 | 2,247,000 | 1,894,000 | ||
| 20-Day Average Volume | 8,395,359 | 3,052,595 | 1,280,100 | ||
| Previous Close | 179.45 | 106.18 | 202.46 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 183.19 | 105.07 | 201.13 | ||
| 20-Day Raw Stochastic | 44.63% | 58.07% | 74.13% | ||
| 20-Day Relative Strength | 55.14% | 54.97% | 49.77% | ||
| Weighted Alpha | +62.81 | -9.40 | -31.63 | ||
| Today's Opinion | 72% Buy | 100% Buy | 88% Sell | ||
| Previous Opinion | 72% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.87% since 07/13/21 | +6.47% since 04/19/24 | +7.47% since 04/19/24 | ||
| Low | 178.51 on 07/19/21 | 99.30 on 04/22/24 | 192.75 on 04/23/24 | ||
| High | 187.45 on 07/14/21 | 111.29 on 04/24/24 | 210.83 on 04/26/24 | ||
| 1-Month | |||||
| %Chg | +1.00% since 06/18/21 | +0.52% since 03/26/24 | -1.47% since 03/26/24 | ||
| Low | 178.51 on 07/19/21 | 97.00 on 04/03/24 | 189.44 on 04/19/24 | ||
| High | 187.45 on 07/14/21 | 115.89 on 04/09/24 | 217.57 on 03/28/24 | ||
| 3-Month | |||||
| %Chg | +9.58% since 04/20/21 | +6.05% since 01/26/24 | -14.67% since 01/26/24 | ||
| Low | 164.83 on 04/29/21 | 84.06 on 02/13/24 | 189.44 on 04/19/24 | ||
| High | 187.45 on 07/14/21 | 115.89 on 04/09/24 | 251.99 on 01/31/24 | ||
| 6-Month | |||||
| %Chg | +15.70% since 01/20/21 | +42.10% since 10/26/23 | -13.35% since 10/26/23 | ||
| Low | 146.97 on 03/04/21 | 62.55 on 11/02/23 | 189.44 on 04/19/24 | ||
| High | 187.45 on 07/14/21 | 115.97 on 01/08/24 | 268.30 on 01/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 40,335,968 | 41,339,556 | 30,415,212 | ||
| Shares Outstanding, K | 221,019 | 382,880 | 145,597 | ||
| Annual Sales | 6,069,900,000 | 6,848,000,000 | 9,835,600,000 | ||
| Annual Net Income | 603,400,000 | -4,714,000,000 | 1,161,100,000 | ||
| Last Quarter Sales | 1,636,500,000 | 2,811,000,000 | 2,386,300,000 | ||
| Last Quarter Net Income | 636,000,000 | 217,000,000 | 249,700,000 | ||
| 60-Month Beta | 1.25 | 1.62 | -0.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 3.52 on 04/30/21 | 0.55 on 02/22/24 | 3.67 on 04/24/24 | ||
| Latest Earnings Date | 07/29/21 | 05/02/24 | 04/24/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.07 | 0.00 | 13.50 | ||